Contact with chambers should be made through the Practice Management Team. They are happy to discuss client requirements and provide further information on such matters as the expertise and experience of individual members, fees, working practices and languages spoken. We have members able to work in French, German, Italian, Spanish, Dutch, Swedish, Greek and Chinese (Mandarin).
Outside working hours, a member of our team is always available to be contacted on matters of an urgent nature. Contact should be made using the Chambers main number or email.
For our Singapore office, for client enquiries please contact our BD Director, Asia Pacific, Lara Quie and for all other queries please contact Lynn Quek. Out of office hours calls will automatically be diverted to our clerking team in London.
28 Maxwell Road
#02-03 Maxwell Chambers Suites
Singapore 069120
singapore@twentyessex.com
t: +65 62257230
Contact with chambers should be made through the Practice Management Team. They are happy to discuss client requirements and provide further information on such matters as the expertise and experience of individual members, fees, working practices and languages spoken. We have members able to work in French, German, Italian, Spanish, Dutch, Swedish, Greek and Chinese (Mandarin).
Outside working hours, a member of our team is always available to be contacted on matters of an urgent nature. Contact should be made using the Chambers main number or email.
For our Singapore office, for client enquiries please contact our BD Director, Asia Pacific, Lara Quie and for all other queries please contact Lynn Quek. Out of office hours calls will automatically be diverted to our clerking team in London.
28 Maxwell Road
#02-03 Maxwell Chambers Suites
Singapore 069120
singapore@twentyessex.com
t: +65 62257230
Oliver Caplin provides a practitioner’s acute summary and insights on the most recent and precedent setting cases in the areas of Private International Law, IP disputes and their crossover.
Before coming to the Bar, Oliver trained and practised as a medical doctor. As a result of his background, he is developing a predominantly life sciences based commercial and IP practice. He has appeared or advised on cases in both the Patents Court and the IPEC.
In 2017 he was involved in three of the year’s leading pharmaceutical patent disputes concerning where challenges to the validity of a foreign registered patent may be brought: Fujifilm v Abbvie; Chugai v UCB; and Eli Lilly & Co v Genentech Inc.